Published May 10, 2022 | Version v2
Journal article Open

The Frequency and Causes of Benign Leukopenia in Patients Admitted to the Pediatric Hematology Clinic: A Three-Year Study

  • 1. Department of Pediatrics, Elazığ Fethi Sekin City Hospital, Elazığ, Türkiye.
  • 2. Department of Medical Microbiology, Elazığ Fethi Sekin City Hospital, Elazığ, Türkiye.
  • 3. Department of Medical Microbiology, Recep Tayyip Erdoğan University Faculty of Medicine, Rize, Türkiye.

Description

Özet

Lökosit sayısının 3500/μL seviyesinin altında olması lökopeni olarak tanımlanmaktadır. Çoğunlukla sekonder sebeplerle ilişkili olan ve immün sistem görevlerini etkileyebilmesi nedeniyle klinik önem taşıyan lökopeni çocuklarda farklı etiyolojik sebeplere bağlı olarak gelişebilmektedir. Çalışmamızın amacı çocuk hematoloji polikliniğine başvuran hastalarda benign lökopeni sıklığını ve etiyolojik sebeplerini belirlemektir. Bu retrospektif çalışmada 2019-2021 yılları arasında Elazığ Fethi Sekin Şehir Hastanesi Çocuk Hematoloji polikliniğine başvuran ve lökosit sayıları 3500/μL'nin altında olan hastalara ait veriler incelendi. Otoimmün hastalık, malignite, aplastik anemi ve kronik nötropenisi olan hastalar çalışmaya dahil edilmedi. Polikliniğimize başvuran 2500 hasta incelendi ve lökopeni insidansı %3.32 olarak bulundu. Lökopeni tespit edilen 83 hastanın 44'ü erkek (%53) ve 39'u kız (%47) hastalar olup, hastaların ortalama yaşı 8.5±4.5 yıl idi. Hastaların ortalama lökosit sayısı 2950±450/μL, ortalama lökopeni süresi 7.5±2.5 gün, ortalama takip süreleri 14±5 gün olarak tespit edildi ve tüm hastalarda lökopeninin düzeldiği gözlemlendi. Lökopeninin en sık nedenleri sırasıyla enfeksiyonlar %68.7 (57/83), vitamin B12 eksikliği %14.5 (12/83) ve ilaç kullanımı %10.8 (9/83) olarak tespit edildi. Çalışmamızda çocukluk çağında akut geçici lökopeni nedenleri arasında en sık sebebin enfeksiyon kaynaklı olduğu tespit edilirken, vitamin B12 eksikliğinin de lökopeniye sebep olabileceği gözlemlenmiş olup, bu olgularda lökopeninin tedavi ile düzeldiği saptanmıştır.

Abstract

The condition where leukocyte cell count is below 3500/μL is known as leukopenia. In children, leukopenia, which is mostly associated with secondary causes and has clinical importance because it can affect immune system functions, may develop due to various etiological reasons. The aim of our study is to determine the frequency and etiological causes of benign leukopenia in patients admitted to the pediatric hematology outpatient clinic. In this retrospective study, the data of the patients who applied to Elazig Fethi Sekin City Hospital Pediatric Hematology outpatient clinic between 2019-2021 and whose leukocyte counts were below 3500/μL were examined. Patients with autoimmune disease, malignancy, aplastic anemia, and chronic neutropenia were excluded. A total of 2500 patients presented to the hematology clinic were analyzed and the incidence of leukopenia was found as 3.32%. Of the 83 cases diagnosed with leukopenia, 44 (53%) were boys and 39 (47%) were girls, and the mean-age of the patients was 8.5±4.5 years. The mean leukocyte count of the patients was 2.950±450/µL, the median leukopenia duration was 7.5±2.5 days, the average follow-up period was 14±5 days and all the patients recovered. The most common causes of leukopenia were infections 68.7% (57/83), vitamin B12 deficiency 14.5% (12/83) and drug use 10.8% (9/83), respectively. In our study, it was determined that the most common cause of acute transient leukopenia in childhood was infection, while it was observed that vitamin B12 deficiency can also cause leukopenia and it improves with treatment in these cases.

Notes

Çocuk Hematoloji Polikliniğine Başvuran Hastalarda Benign Lökopeni Sıklığı ve Nedenleri: Üç Yıllık Çalışma

Files

jmvi.2022.49.v2.pdf

Files (294.4 kB)

Name Size Download all
md5:decec30093c48d3bf4ac01ed202e9ae8
294.4 kB Preview Download

Additional details

References

  • ‎1. Wahlster L, Daley GQ. Progress towards generation of human haematopoietic stem cells. Nat Cell Biol ‎‎2016; 18(11): 1111-7.‎
  • ‎2. Kutlu H, Avci E, Özyurt F. White blood cells detection and classification based on regional convolutional ‎neural networks. Med Hypotheses 2020; 135: 109472.‎
  • ‎3. Skummer P, Kobayashi K, DeRaddo JS, Blackburn T, Schoeneck M, Patel J, et al. Risk Factors for Early ‎Port Infections in Adult Oncologic Patients. J Vasc Interv Radiol 2020; 31(9): 1427-36.‎
  • ‎4. Dinauer MC, Newburger PE. The phagocyte system and disorders of granulopoiesis and granulocyte ‎function. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, Fisher D, Lux SE (eds), Nathan and Oski's ‎hematology of infancy and childhood (7th edition). 2008, WB Saunders Company, Philadelphia, PA. ‎pp:1109-217.‎
  • ‎5. Karavanaki K, Polychronopoulou S, Giannaki M, Haliotis F, Sider B, Brisimitzi M, et al. Transient and ‎chronic neutropenias detected in children with different viral and bacterial infections. Acta Paediatr 2006; ‎‎95(5): 565-72.‎
  • ‎6. Metz J. A high prevalence of biochemical evidence of vitamin B12 or folate deficiency does not translate ‎into a comparable prevalence of anemia. Food Nutr Bull 2008; 29(2 Suppl): S74-85.‎
  • ‎7. Toprak B, Yalcın HZ, Colak A. Vitamin B12 and folate deficiency: should we use a different cutoff value ‎for hematologic disorders? Int J Lab Hematol 2014; 36(4): 409-14.‎
  • ‎8. Ozdemir ZC, Kar YD, Kasaci B, Bor O. Etiological causes and prognosis in children with neutropenia. North ‎Clin Istanb 2021; 8(3): 236-42.‎
  • ‎9. Newburger PE. Autoimmune and other acquired neutropenias. Hematology Am Soc Hematol Educ ‎Program 2016; 2016(1): 38-42.‎
  • ‎10. Ortiz MV, Meier ER, Hsieh MM. Identification and Clinical Characterization of Children With Benign Ethnic ‎Neutropenia. J Pediatr Hematol Oncol 2016; 38(3): e140-3.‎
  • ‎11. Grace RF. Hematologic manifestations of systemic diseases. In: Orkin SH, Fisher DE, Ginsburg D, Look ‎AT, Lux SE, Nathan DG (eds), Nathan and Oski's Hematology and Oncology of Infancy and Childhood (8th ‎edition). 2015, Elsevier Saunders, Philadelphia. pp:1167-203.‎
  • ‎12. Atay MH, Kelkitli E, Özatlı D. Lökosit üretiminde yetersizlik ile giden kazanılmış hastalıklar. Türkiye ‎Klinikleri J Hem Onc-Special Topics 2011; 4(1): 56-8.‎
  • ‎13. Kılıç A, Yıldız İ, Beka H, Ağaçfidan A, Ünüvar A, Yanar Ö, et al. Different clinical presentation of ‎infectious mononucleosis in children: a retrospective analysis of 369 cases. Türk Ped Arş 2012; 47(3): 189-‎‎92.‎
  • ‎14. Çağlar M, Balcı YI, Polat A. Çocuk Hematoloji Polikliniği'ne başvuran hastalarda benign lökopeni sıklığı ‎ve nedenleri. Pam Tıp Derg 2014; 7(1): 53-6.‎
  • ‎15. Hung WC, Hsieh MH. Neutropenia associated with the comedication of quetiapine and valproate in 2 ‎elderly patients. J Clin Psychopharmacol 2012; 32(3): 416-7.‎
  • ‎16. Çağan E, Çağan H, Sürmelihindi D. Metamizol Sodyum Kullanımına Bağlı Agranülositoz. Cukurova ‎Medical Journal 2015; 40(3): 580-3.‎
  • ‎17. Pisciotta AV. Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and ‎their marrow precursors. Blood Rev 1990; 4(4): 226-37.‎
  • ‎18. Krishna R, O'Donovan E, Bain BJ. Neutropenia and anemia with reduced serum vitamin B12. Am J ‎Hematol 2011; 86(5): 417.‎
  • ‎19. Kamel S, Lu Z, Sikaris K. Comment on: Neutropenia and anemia with reduced serum vitamin B 12. Am ‎J Hematol 2012; 87(2): 233-4.‎
  • ‎20. Nafil H, Tazi I, Sifessalam M, Bouchtia M, Mahmal L. Clinical, biological and therapeutic profile of anemia ‎by vitamin B12 deficiency in the department of hematology of Marrakech (Morocco). Bull Soc Pathol Exot ‎‎2013; 106(2): 83-8.‎
  • ‎21. Atay E, Akin M, Ozhan B, Osman O, Karakus YT, Erdogan F. Frequency of hematological findings associated ‎with severe plasma vitamin B12 deficiency in infants and adolescents. Clin Lab 2014; 60(4): 659-62.‎